Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis

Figure 3 Effect of fetal kidney stem cells therapy on renal function in rats with cisplatin induced acute renal failure. The changes in the levels of (A) blood urea nitrogen (BUN) and (B) serum creatinine in healthy control, saline treated and fetal kidney stem cells (fKSC) treated groups on day 0, 3 and 7 after fKSC therapy. Values expressed as Mean ± SE. ^aP < 0.05 for saline and fKSC treated vs healthy control group; ^cP < 0.05 for fKSC vs saline treated group.